BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, January 24, 2026
Home » Authors » Mark McCarty

Articles by Mark McCarty

Washington roundup: House, Senate adopt and pass unified FDA bill for tobacco

June 15, 2009
By Mark McCarty

Panel eyes ultrafiltration for congestive heart failure

June 12, 2009
By Mark McCarty

Washington roundup: Mainline leaves diagnostics business after warning letter

June 11, 2009
By Mark McCarty

Washington roundup: Family business owner: FDA audits 'rudimentary' in 60s

June 10, 2009
By Mark McCarty

Washington roundup: NIH to license aortic valve stent, other technologies

June 9, 2009
By Mark McCarty

Washington roundup: Mainline leaves diagnostics business after warning letter

June 8, 2009
By Mark McCarty

Clinical sites see money as issue when looking at PAS

June 8, 2009
By Mark McCarty
SILVER SPRING, Maryland – The post-approval study (PAS) is one of the most frustrating parts of the development process for makers of novel devices, not just because patients are not particularly eager to enroll. (Medical Device Daily)
Read More

Comparative effectiveness not seen bending cost curve

June 5, 2009
By Mark McCarty

Scrutiny of device industry unlikely to ebb anytime soon

June 5, 2009
By Mark McCarty
WASHINGTON — The second day of this year's annual meeting of the Medical Device Manufacturers Association (MDMA; Washington) covered a couple of hot-button topics, and a session that got the audience's rapt attention was one that dealt with compliance issues in an era of increasing governmental scrutiny. (Medical Device Daily)
Read More

Schultz: de novo 510(k) path not used to 'maximum effect'

June 4, 2009
By Mark McCarty
WASHINGTON – Dan Schultz, MD, director of the Center for Devices and Radiological Health at FDA, gave a brief address at this year's annual meeting of the Medical Device Manufacturers Association (MDMA; Washington), and had a lot to say about a lot of things. (Medical Device Daily)
Read More
Previous 1 2 … 507 508 509 510 511 512 513 514 515 … 578 579 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 23, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 23, 2026.
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • Illustration of magnifying glass inspecting brain

    Neurotrimin unveiled as marker in intellectual disability

    BioWorld Science
    Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
  • DNA mutations or genetic disorder concept art

    Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

    BioWorld Science

    Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing